2. EARDLEY I. THE INCIDENCE, PREVALENCE, AND NATURAL HISTORY OF ERECTILE DYSFUNCTION.

June 3, 2018

Additional sources searched included the Agency for Healthcare Research and Quality, Cochrane database, Essential Evidence, National Guideline Clearinghouse, and U.S. Preventive Services Task Force. Devices are available to measure the number, duration, and rigidity of erections during sleep. Reprinted with permission from Heidelbaugh JJ. Management of erectile dysfunction.

Surgically implanted penile prostheses are a third-line treatment option for ED when other treatments have been ineffective. Patients can obtain vacuum devices at medical supply companies by presenting a physician’s prescription. A constricting ring is then slid off the base of the tube onto the penis to maintain the erection.

Penile fibrosis is another possible adverse effect; in one study, persistent fibrotic changes occurred in 4.9% of patients using intracavernosal alprostadil for four years. Second-line treatments for ED include alprostadil (Caverject) and vacuum devices. Lower doses should be used in patients with chronic kidney disease or moderate liver impairment.

Diagnosis and Management of Erectile Dysfunction. Algorithm for the diagnosis and management of erectile dysfunction. ED is associated with an increased risk of CVD, coronary artery disease (CAD), stroke, and all-cause mortality, and it is probably an independent risk factor for CVD.

ED and CVD share similar risk factors, including older age, hypertension, dyslipidemia, smoking, obesity, and diabetes. History and physical examination; if venous leakage is suspected, consider urology consultation for venous flow testing. D. Completely impotent: never able to get and keep an erection good enough for sexual intercourse.

C. Moderately impotent: sometimes able to get and keep an erection good enough for sexual intercourse. B. Minimally impotent: usually able to get and keep an erection good enough for sexual intercourse. A. Not impotent: always able to get and keep an erection good enough for sexual intercourse.

Impotence means not being able to get and keep an erection that is rigid enough for satisfactory sexual activity. Surgically implanted penile prostheses are an option when other treatments have been ineffective. Oral phosphodiesterase-5 inhibitors are the first-line treatments for ED. Second-line treatments include alprostadil and vacuum devices.

ED is associated with an increased risk of cardiovascular disease, particularly in men with metabolic syndrome. The first dose of the injection therapy is usually administered under the supervision of a health care provider. These medications include alprostadil (Edex), papavarine and phentolamine.

After the penis is erect, a restrictive band is placed at the base of the penis to trap the blood in the penis. This 30-40 minute outpatient operation has a 98 percent patient and partner satisfaction rate, making penile implant the most successful operation for ED. The operation is covered by nearly all insurance, and is the only ED treatment covered by Medicare. These medications should never be taken with nitrate drugs for chest pain, and they should be taken under close supervision by a medical professional in any patient taking alpha blockers for hypertension or enlarged prostate.

Oral medications used to treat ED include, sildenofil (Fildena), Fildena (Fildena), vardenafil (Levitra or Staxyn), and avanafil (Stendra).
https://medicamentfrance.eu/
http://www1.american.edu/TED/viagra.htm
https://phhp-bahealthscience-new.sites.medinfo.ufl.edu/files/2016/09/jsc1600151.pdf
https://www.purdue.edu/hr/Benefits/currentEmployees/Medical/rxCoverage.html
https://www.bloomberg.com/view/articles/2017-06-20/get-generic-drugs-to-market-faster